Mutual Pharmaceuticals: 1 Responses from issuers and sponsors to the second round of review enquiry letter (revised draft) (Financial data update for the half year 2022)

SZSI · Aug 31, 2022 00:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.